Home  /   Products  /   Hepatotropic, choleretic  /   Phospholipides, sodium glycyrrhizate (Phosphogliv) intravenous 2.5 g – [5 vials]

Phospholipides, sodium glycyrrhizate (Phosphogliv) intravenous 2.5 g – [5 vials]

$74.52

Hepatoprotective agent

Phospholipides, sodium glycyrrhizate (Phosphogliv) intravenous injections are indicated in fatty liver degeneration, alcoholic or toxic liver damage.

SKU: 63191 Category:

Description

Phospholipides, sodium glycyrrhizate (Phosphogliv) Pharmacodynamics
Combined agent. It has hepatoprotective, membrane stabilizing and antiviral effect.

 

Indications
– Fatty liver degeneration (hepatosis);
– Alcoholic, toxic, including drug-induced liver damage;
– In the treatment of viral hepatitis, cirrhosis and psoriasis.

 

Contraindications .
– Hypersensitivity to glycyrrhizic acid, phosphatidylcholine or other components of the drug;
– Antiphospholipid syndrome;
– Pregnancy (data on efficacy and safety are insufficient);
– Breast-feeding (data on efficacy and safety are insufficient);
– Childhood under 12 years of age (data about efficacy and safety are insufficient).

 

Dosage and administration
  • Adults and children over 12 years of age.
  • Intravenously, dissolving the powder in 10 ml of water for injection.
  • Carry out intravenous injection slowly.
  • Administer 10 ml daily 2 times a day in the morning and in the evening for 10 days and then switch to oral administration of the drug as capsules. Course duration may be increased upon doctor’s recommendation.